Use of cannabidiol (CBD) for the treatment of chronic pain.

Urits Ivan, et al.
Best Practice & Research Clinical Anaesthesiology, 2020

Abstract

Chronic pain can be recurrent or constant pain that lasts for longer than 3 months and can result in disability, suffering, and a physical disturbance. Related to the complex nature of chronic pain, treatments have a pharmacological and non-pharmacological approach. Due to the opioid epidemic, alternative therapies have been introduced, and components of the plant Cannabis Sativa, Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) have gained recent interest as a choice of treatment. The exact mechanism for CBD is currently unknown, but unlike the CBD's psychoactive counterpart, THC, the side effects of CBD itself have been shown to be overall much more benign. The current pharmaceutical products for the treatment of chronic pain are known as nabiximols, and they contain a ratio of THC combined with CBD, which has been promising. This review focuses on the treatment efficacy of CBD, THC: CBD-based treatments for chronic pain and adverse events with each.

Keywords

cannabidiol; chronic pain; nabiximols.

Copyright © 2020. Published by Elsevier Ltd.

Conflict of interest statement

Declaration of Competing Interest The authors have no conflicts of interest to disclose.

PMID:33004159
DOI:10.1016/j.bpa.2020.06.004
Category:Hemp Products

The best supplements with Cannabidiol in Hemp Products category:

Articles similar to "Use of cannabidiol (CBD) for the treatment of chronic pain."

  • The significance of Cannabidiol for Hemp Products: Medical use of cannabinoids. (Cannabinoid receptors, endocannabinoids and the enzymes responsible for their biosynthesis and degradation constitute the endocannabinoid system...)
  • The impact of Cannabidiol on Hemp Products: Effectiveness of cannabidiol oil for pediatric anxiety and insomnia as part of posttraumatic stress disorder: a case report. (INTRODUCTION:Anxiety and sleep disorders are often the result of posttraumatic stress disorder and can contribute to an impaired ability to focus and to demonstration of oppositional behaviors...)
  • The significance of Cannabidiol for Hemp Products: Hemp (Cannabis sativa L.) seed oil: analytical and phytochemical characterization of the unsaponifiable fraction. (Non-drug varieties of Cannabis sativa L...)
  • The role of Cannabidiol in Hemp Products: The composition of hemp seed oil and its potential as an important source of nutrition. (The fatty acid and natural product content of hemp seed oil was analyzed by GC-MS and LC-MS...)
  • The impact of Cannabidiol on Hemp Products: Cannabis-based medicines for chronic neuropathic pain in adults. ( This review is one of a series on drugs used to treat chronic neuropathic pain... The potential benefits of cannabis-based medicine (herbal cannabis, plant-derived or synthetic THC, THC/CBD oromucosal spray) in chronic neuropathic pain might be outweighed by their potential harms. The quality of evidence for pain relief outcomes reflects the exclusion of participants with a history of substance abuse and other significant comorbidities from the studies, together with their small sample sizes. )
  • The significance of Cannabidiol for Hemp Products: The Role of Cannabidiol (CBD) in Chronic Pain Management: An Assessment of Current Evidence. (Purpose of review: Given the growing challenges in chronic pain management coupled with the ongoing consequences of the opioid epidemic, pain management practitioners are looking into more effective, innovative, and safer alternatives to treat pain... The potential benefits of cannabis-based medicine (herbal cannabis, plant-derived or synthetic THC, THC/CBD oromucosal spray) in chronic neuropathic pain might be outweighed by their potential harms. The quality of evidence for pain relief outcomes reflects the exclusion of participants with a history of substance abuse and other significant comorbidities from the studies, together with their small sample sizes. )
  • The role of Cannabidiol in Hemp Products: Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain. (Objective: This study investigated whether local intramuscular injection of non-psychoactive cannabinoids, cannabidiol (CBD), cannabinol (CBN), cannabichromene (CBC) and their combinations can decrease nerve growth factor (NGF)-induced masticatory muscle sensitization in female rats... These results suggest that peripheral application of these non-psychoactive cannabinoids may provide analgesic relief for chronic muscle pain disorders such as temporomandibular disorders and fibromyalgia without central side effects. )

Previous article

Flavonoid glycosides and cannabinoids from the pollen of Cannabis sativa L.

Next article

Cannabis-based medicines for chronic neuropathic pain in adults.